Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 498.95
-9.60 (-1.89%)
Mar 9, 2026, 3:29 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 25.31 billion as of March 9, 2026. Its market cap has decreased by -52.35% in one year.
Market Cap
25.31B
Enterprise Value
26.64B
Revenue
8.11B
Ranking
n/a
PE Ratio
132.35
Stock Price
498.95
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 25.31B, an increase of 3,379.25%. That is a compound annual growth rate of 94.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 25.79B | -32.99% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 63.47B |
| Sun Pharma Advanced Research Company | 40.23B |
| Innova Captab | 38.91B |
| RPG Life Sciences | 30.97B |
| Solara Active Pharma Sciences | 22.11B |
| Indoco Remedies | 18.31B |
| Windlas Biotech | 15.58B |
| Ind-Swift Laboratories | 11.87B |